Friday, October 1, 2021

// // Leave a Comment

Evidence-Based Recommendations on the Use of Casirivimab + Imdevimab, and Sotrovimab for Adults in Ontario

Antibody testing is not required in mildly ill patients. In patients with no history of COVID-19 infection or full vaccination, casirivimab + imdevimab at a ...

from Google Alert - health https://ift.tt/3mjlgB5
via IFTTT

0 comments:

Post a Comment